WallStreetZenWallStreetZen

How to Buy Cognition Therapeutics Stock

Cognition Therapeutics Inc

Cognition Therapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.

Cognition Therapeutics stock last closed at $1.84, down 3.16% from the previous day, and has increased 7.6% in one year. It has overperformed other stocks in the Biotechnology industry by 0.34 percentage points. Cognition Therapeutics stock is currently +104.44% from its 52-week low of $0.90, and -47.28% from its 52-week high of $3.49.

As of Apr 18, 2024, there are 39M shares of CGTX outstanding. The market capitalization of CGTX is $71.76M. In the past 24 hours, 99,177 CGTX shares were traded.

How to Buy Cognition Therapeutics Stock

Not sure how to invest in Cognition Therapeutics stock? Here's how.
  1. Figure out where to buy Cognition Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Cognition Therapeutics stock.
  2. Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Put funds into your investment account: Pick your method of payment and add your information.
  4. Analyze Cognition Therapeutics stock: The Cognition Therapeutics ticker symbol is CGTX. Is Cognition Therapeutics stock a good investment? Should you buy shares of CGTX? How do CGTX's underlying business fundamentals look? Do top analysts think Cognition Therapeutics is a good buy? Why has CGTX's stock price moved recently? (Hint: Our stock research website can help you understand if CGTX is a good stock to buy).
  5. Make your CGTX trade: Decide if you will purchase CGTX shares at the current market price or use a limit order to purchase CGTX shares at a specific price.
  6. Get updates on your investment in CGTX: Create a watchlist to keep track of your position in Cognition Therapeutics shares.

Step 1: Figure out where to buy Cognition Therapeutics stock

You need an online brokerage account to access the NASDAQ market and buy CGTX stock.

A brokerage account allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our experience, eToro is the best online stock brokerage. eToro gives you:

  • Invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to world financial markets: From Tech to Financial Services, New York to London — you can fill your portfolio with stocks from the globe's leading exchanges.
  • Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by creating an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've chosen your brokerage, it's time to fill out some personal details so you are able to buy CGTX today.

How to Set Up a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal info to start your new trading account.
  1. Send your details by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your investment account

Now that you've finished signing up on the best free stock trading app, you need to deposit funds:

Watch the video below to see the process of transferring money into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Cognition Therapeutics stock

After you have selected the best place to buy Cognition Therapeutics stock, it's absolutely critical to research their stock prior to buying, so you can comprehend the risk and upside.

Cognition Therapeutics shares data

CGTX Price
$1.84
1w %
-11.96%
1y %
7.6%
5y %
N/A
P/E
-2.14x
P/B
2.93x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$25.79M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$71.76M
Next Earnings
May 4, 2024
Next Dividend
N/A

CGTX Fundamentals

WallStreetZen was created to help average investors do more accurate fundamental analysis.

You can view all of the due diligence checks on CGTX's stock page.

What is the fair value of CGTX stock?

Investors use many financial metrics, analyses, models, and charts to gauge CGTX's true value.

Using relative valuations methods:

  • CGTX may be undervalued based on its P/B ratio of 2.93x, relative to Biotechnology industry P/B ratio of 5.76x

You can do more valuation analysis on CGTX's stock here.

CGTX Financial Health

Pros:

  • There are more short-term assets than long-term liabilities on the CGTX balance sheet.
  • There are more short-term assets than short-term liabilities on the CGTX balance sheet.
  • CGTX has cash burn of 16165000. It has sufficient cash and short-term investments to cover this for at least one year.

Cons:

  • CGTX has a relatively high debt to equity ratio of 0.44.
  • CGTX has $29.92M in cash and short term investments. This is not enough to cover its annual cash burn of $16.17M.

Is it a good time to buy CGTX stock, according to Wall Street analysts?

Out of 2 sell side analysts who monitor CGTX, the consensus analyst rating on CGTX is a Strong Buy

Please keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.

You can dig deeper into what analysts are projecting on the Cognition Therapeutics stock forecast page.

Metrics for Advanced CGTX Traders

SMA10
1.97
SMA20
1.92
SMA50
1.97
SMA100
1.93
SMA200
1.67
MACD
-0.01
MACD Signal
0
MACD Histogram
-0.01
RSI
43.65
Stochastic %K
24.68
Stochastic %D
31.56
StochRSI %K
20.96
StochRSI %D
29.22

Are CGTX insiders buying or selling the stock?

In the last year, insiders at CGTX have bought more shares than they have sold.

Lisa Ricciardi, CEO President of CGTX, was the latest CGTX insider to buy. They bought $9,975.00 worth of CGTX shares on Mar 14, 2024.

Research more about who owns CGTX shares here.

Can I get consistent income from CGTX stock?

No, Cognition Therapeutics doesn't provide an income stream by paying out dividends.

What do other traders have to say about CGTX?

One of the major reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other investors have to say.

Step 5: Make your CGTX trade

There are two main order types:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are generally the easiest way to buy.
  • Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
    If you want to ensure you're buying or selling at a specific price, use a limit order.

Hit the Open Trade button and eToro will execute your order.

If you want more help with buying stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Get updates on your investment in CGTX

Now that you own some CGTX shares, you'll want to stay up-to-date on your stock purchase.

Make a watchlist to keep track of your CGTX stock.

CGTX Feed

How to Buy Stock in Cognition Therapeutics

To summarize, here are the 6 steps for buying Cognition Therapeutics stock:

  1. Figure out where to buy Cognition Therapeutics stock
  2. Open a brokerage account
  3. Put funds into your investment account
  4. Analyze Cognition Therapeutics stock
  5. Make your CGTX trade
  6. Get updates on your investment in CGTX

If you need a online brokerage, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get updates on your new investment in Cognition Therapeutics, click the button below.

NASDAQ: CGTX
$1.84-0.06 (-3.16%)
Updated Apr 18, 2024
Open eToro Account
NASDAQ: CGTX
$1.84-0.06 (-3.16%)
Updated Apr 18, 2024
Open eToro Account

FAQ

How much does it cost to buy one Cognition Therapeutics share?

As of Apr 18, 2024, it costs $1.84 to buy one share of Cognition Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.92, you can buy 0.5 shares of CGTX.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Cognition Therapeutics stock?

According to 2 Wall Street analysts who monitor Cognition Therapeutics, their consensus recommendation is to buy Cognition Therapeutics stock.

What is the best way to buy Cognition Therapeutics stock?

One way to place an order for Cognition Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.